Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 28.3213.968.0318.19-3.74

What is the latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 28.32 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202528.32
Mar202413.96
Mar20238.03
Mar202218.19
Mar2021-3.74

How is Core EBITDA Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 28.32
102.87
Mar2024 13.96
73.85
Mar2023 8.03
-55.85
Mar2022 18.19
Positive
Mar2021 -3.74 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹53,988.6 Cr -1.2% -2.3% 27.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,580.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹180,069.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,919.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,310.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,402.0 Cr -4.3% -8% -4.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.2%

-2.3%

27.2%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses